Tanya Welch
Adult Health · Newton, TXNPI 1831704105
Payments from drug & device makers
Across 142 payments — averaging $21.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$480
- UCB, Inc.$282
- Pfizer$272
- Novartis$194
- Jazz Pharmaceuticals Inc.$150
- Argenx US, Inc.$145
- plus $2K from 29 others
What the payments were for
- Food & beverage$3,081100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 26 | $480 |
| UCB, Inc. | 9 | $282 |
| Pfizer | 17 | $272 |
| Novartis | 8 | $194 |
| Jazz Pharmaceuticals Inc. | 6 | $150 |
| Argenx US, Inc. | 5 | $145 |
| Solventum Corporation | 2 | $136 |
| Teva Pharmaceuticals USA, Inc. | 7 | $130 |
| Neurelis, Inc. | 3 | $125 |
| SK Life Science, Inc. | 5 | $116 |
| Lundbeck LLC | 7 | $114 |
| Eisai Inc. | 6 | $101 |
| Biogen | 4 | $86 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $81 |
| EMD Serono, Inc. | 5 | $74 |
| Sumitomo Pharma America, Inc. | 3 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $57 |
| Mallinckrodt Hospital Products Inc. | 2 | $47 |
| Grifols USA, LLC | 2 | $42 |
| AstraZeneca(2 entities) | 2 | $42 |
| Upsher-smith Laboratories LLC | 2 | $40 |
| Amneal Pharmaceuticals LLC | 2 | $35 |
| ANI Pharmaceuticals, Inc. | 1 | $30 |
| Tanabe Pharma America, Inc. | 2 | $28 |
| Sanofi | 1 | $27 |
| Kyowa Kirin, Inc. | 1 | $25 |
| Puma Biotechnology, Inc. | 1 | $25 |
| Genentech USA, Inc. | 1 | $24 |
| Neurocrine Biosciences, Inc. | 1 | $19 |
| Immedica Pharma US, Inc. | 1 | $18 |
| Avion Pharmaceuticals | 1 | $18 |
| Reprise Biomedical, Inc. | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $13 |
| Insightec,inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACTIV.A.C.$127
- 3M Cavilon$127
- PROMOGRAN PRISMA$127
- V.A.C. DERMATAC$127
- 3M Coban$127
How this compares
$3,081 in reported general payments places this provider in the 80th percentile of 933 adult health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rebif RebidoseInterferon Beta-1a/Albumin | 11 | $113,725 |
| EpidiolexCannabidiol (Cbd) | 17 | $89,643 |
| Nurtec OdtRimegepant Sulfate | 27 | $50,750 |
| UbrelvyUbrogepant | 19 | $32,063 |
| ValtocoDiazepam | 11 | $30,777 |
| QuliptaAtogepant | 14 | $29,086 |
| RytaryCarbidopa/Levodopa | 14 | $22,001 |
| Zonisamide | 331 | $7,486 |
| GraliseGabapentin | 23 | $7,397 |
| Gabapentin | 217 | $6,310 |
| Memantine Hcl | 225 | $5,402 |
| Oxcarbazepine | 62 | $5,321 |
| Pregabalin | 122 | $4,500 |
| Ropinirole Hcl | 114 | $4,173 |
| Rivastigmine | 17 | $4,062 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy, Qulipta | $480 | $61,14933 claims |
| PfizerNurtec Odt | $272 | $50,75027 claims |
| Neurelis, Inc.Valtoco | $125 | $30,77711 claims |
| Amneal Pharmaceuticals LLCRytary | $35 | $22,00114 claims |
| Upsher-smith Laboratories LLCTopiramate | $40 | $81562 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 933 adult health providers in Texas.
Other adult health in Newton
- Misty SheddAllen$863K
- Melodie YoungDallas$700K
- Cynthia BedellPlano$168K
- Elizabeth Wedberg SivamAustin$71K
- Mary SalazarSan Antonio$68K
- Eric KlappholzDallas$44K
- Christin TouchetKingwood$43K
- Yulia LyuboslavskyAustin$36K
- Meghan MurphyAustin$29K
- Sandra CareyGrapevine$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.